Sign inGet started

Kamen Robert

Insider CIK 1693540 · JNCE Director · NTGN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
JNCE Jounce Therapeutics, Inc. D To issuer deriv2023-05-032023-05-0415,700— $00SEC↗
JNCE Jounce Therapeutics, Inc. D To issuer deriv2023-05-032023-05-0415,700— $00SEC↗
JNCE Jounce Therapeutics, Inc. D To issuer deriv2023-05-032023-05-0410,840— $00SEC↗
JNCE Jounce Therapeutics, Inc. D To issuer deriv2023-05-032023-05-0415,700— $00SEC↗
JNCE Jounce Therapeutics, Inc. D To issuer deriv2023-05-032023-05-0413,550— $00SEC↗
JNCE Jounce Therapeutics, Inc. D To issuer deriv2023-05-032023-05-0420,000— $00SEC↗
JNCE Jounce Therapeutics, Inc. U Tender2023-05-032023-05-0433,875— $00SEC↗
JNCE Jounce Therapeutics, Inc. U Tender2023-05-032023-05-0460,975— $00SEC↗
JNCE Jounce Therapeutics, Inc. A Award deriv2022-06-242022-06-2820,000— $020,000SEC↗
JNCE Jounce Therapeutics, Inc. A Award deriv2021-06-182021-06-2215,700— $015,700SEC↗
JNCE Jounce Therapeutics, Inc. A Award deriv2020-06-262020-07-0215,700— $015,700SEC↗
JNCE Jounce Therapeutics, Inc. A Award deriv2020-06-262020-06-2913,550— $013,550SEC↗
NTGN Neon Therapeutics, Inc. D To issuer deriv2020-05-062020-05-0618,500— $00SEC↗
NTGN Neon Therapeutics, Inc. D To issuer deriv2020-05-062020-05-0614,000— $00SEC↗
NTGN Neon Therapeutics, Inc. A Award deriv2019-06-252019-06-2718,500— $018,500SEC↗
JNCE Jounce Therapeutics, Inc. A Award deriv2019-06-122019-06-1315,700— $015,700SEC↗
JNCE Jounce Therapeutics, Inc. A Award deriv2018-06-192018-06-2113,550— $013,550SEC↗